phenylalanine and insulin glargine

phenylalanine has been researched along with insulin glargine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hussar, DA1
Ashwell, SG; Dashora, UK; Home, PD; Sibal, L1
Chung, HS; Jun, HJ; Kim, MK; Kim, TK; Ko, JH; Kwon, MJ; Lee, SH; Oh, MK; Park, JH; Rhee, BD; Suk, JH; Yoon, CS1

Trials

2 trial(s) available for phenylalanine and insulin glargine

ArticleYear
Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.
    Diabetic medicine : a journal of the British Diabetic Association, 2007, Volume: 24, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Blood Glucose; Blood Glucose Self-Monitoring; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Time Factors

2007
Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insulin glargine in patients with type 2 diabetes.
    Diabetes research and clinical practice, 2011, Volume: 92, Issue:3

    Topics: Acarbose; Adult; Aged; Aged, 80 and over; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Fasting; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period; Treatment Outcome

2011

Other Studies

1 other study(ies) available for phenylalanine and insulin glargine

ArticleYear
New drugs 2002, part 1.
    Nursing, 2002, Volume: 32, Issue:1

    Topics: Amides; Aminosalicylic Acids; Anti-Ulcer Agents; Antipsychotic Agents; Bimatoprost; Cloprostenol; Cyclohexanes; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Galantamine; Glaucoma; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Lipids; Mesalamine; Nateglinide; Nootropic Agents; Phenylalanine; Phenylhydrazines; Piperazines; Thiazoles; Travoprost

2002